There were 301 press releases posted in the last 24 hours and 401,743 in the last 365 days.
CHARLOTTE, N.C., March 29, 2023 (GLOBE NEWSWIRE) -- LPL Financial LLC (Nasdaq:LPLA) announced today that financial advisor Kemp Cunningham CFP®, MBA has joined LPL Financial’s broker-dealer, RIA and custodial platforms. He reported having served …
The BIIB080 Phase 1b clinical study is the first to show a reduction of this magnitude in tau PET across brain regions Phase 1b Study of BIIB080 showed dose-dependent and sustained reduction of tau protein (CSF t-tau and p-tau181) in the cerebral spinal …
Boston, Massachusetts, March 29, 2023 (GLOBE NEWSWIRE) -- HYCU, Inc., the world’s fastest-growing multi-cloud data protection as a service company, today announced the company has been recognized by CRN®, a brand of The Channel Company, with a prestigious …
SAN FRANCISCO, March 29, 2023 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced financial results for the fourth quarter and …
– Phase 2b clinical trial for AB-2004 in autism irritability ongoing and enrollment anticipated to be complete by end of 2023 – – IND-enabling studies ongoing for Parkinson’s Disease development candidate to support a Phase 1 clinical trial initiation in …
CAMBRIDGE, Mass., March 29, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul …
ARLINGTON, Mass., March 29, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of …
WILMINGTON, Mass., March 29, 2023 (GLOBE NEWSWIRE) -- UniFirst Corporation (NYSE: UNF) (the “Company,” “UniFirst” or “we”) today reported results for its second quarter ended February 25, 2023 as compared to the corresponding period in the prior fiscal …
Revenue of $66 Million for Full Year 2022 Meets Full Year Outlook Company Achieves Positive Gross Margins in Q4 BEDFORD, Mass. , March 29, 2023 (GLOBE NEWSWIRE) -- Berkshire Grey Inc. (Nasdaq: BGRY) (the “Company”), a leader in AI-enabled robotic solutions …
BOSTON, March 29, 2023 (GLOBE NEWSWIRE) -- DraftKings Inc. (Nasdaq: DKNG) announced today that DK Horse, the digital gaming operator’s first-ever horse racing product, has launched in twelve (12) states and expects to launch in additional states by the …
BOSTON, March 29, 2023 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle (EEV™) therapeutics as a new class of …
– Phenylketonuria (PKU) program on track for Phase 3 trial initiation in first half of 2023 – – Rare Pediatric Disease Designation granted for SYNB1934 for PKU and SYNB1353 for homocystinuria (HCU) – - Platform presentation and two poster presentations at …
BOSTON, March 29, 2023 (GLOBE NEWSWIRE) -- Midaxo, provider of the leading software platform for corporate dealmaking, today announced the launch of the new Midaxo Corporate Development Cloud. After a decade as the leading software solution for companies …
An innovative and first of its kind Personal Diversity Challenge Program is hosting their 2nd ever nation-wide challenge and is seeking additional participants NORTH ANDOVER, MA, UNITED STATES, March 28, 2023 /EINPresswire.com/ -- An innovative and …
BEPC selected Sara A. Wells to receive its highest honor, the BEPC Excellence Award, which recognizes professional excellence in the area of estate planning. WESTFORD, MA, USA, March 28, 2023 /EINPresswire.com/ -- The Boston Estate Planning Council ( …
NATICK, MASSACHUSETTS, UNITED STATES OF AMERICA, March 28, 2023 /EINPresswire.com/ -- NeuroDex, Inc.’s approved application, titled “Clinical Validation of a Robust Blood Test Using Neuron-Derived Exosomes for Detection of Alpha-Synuclein/TDP43 …
-- Clover’s two premium respiratory vaccines approved in China (COVID-19 and seasonal influenza) are expected to drive meaningful and diversified revenues in 2023 with continued growth thereafter -- -- Clover’s COVID-19 vaccine now listed in 24 provinces …
--三叶草生物在中国拥有两款优质的已获批的呼吸道领域疫苗（新冠疫苗和季节性流感疫苗），预计将在2023年带来有意义和多元的收入，保持连续的增长势头-- --三叶草生物的新冠疫苗现已在中国24个省市列入采购目录（人口覆盖率>80%），并处于市场有利地位，将成为即将到来的加强针接种普及的主要参与者; 预计2023年上半年在至少另外一个国家获得紧急使用授权（EUA），并签署双边供应协议-- --作为中国大陆唯一获批的进口四价季节性流感疫苗，AdimFlu-S（QIS）的商业化生产正在进行中，并有望在2023 …
Two agriculture solutions now under regulatory review, pending EPA approval: Calantha™, a solution to protect potatoes, and a separate solution to protect honeybees from Varroa mite Updated clinical strategy to accelerate development of its next-generation …
ZKN-013 in development for treatment of recessive dystrophic epidermolysis bullosa (RDEB) and junctional epidermolysis bullosa (JEB) Additional IND filing for ZKN-013 for treatment of familial adenomatous polyposis (FAP) expected in first half of 2023 …
